4 Stocks to Profit From Obamacare’s Next Phase
Merck, Roche, Express Scripts, and LabCorp stand to benefit from an increased focus on cost control and improved outcomes.
The first five years of the Affordable Care Act were largely focused on increasing accessibility to health care. Now, we're moving into the next phase, which is concentrated on cost control and improved outcomes.
With those two goals in mind, four names jump out at us as companies that will benefit in this new phase. The first two are Merck (MRK) and Roche (RHHBY). These two companies have a number of therapeutic agents in their pipelines that will make a big difference on the quality side, which means they will deliver better health outcomes.
Debbie Wang does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.